InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Flesher Gregory J., Chairman & CEO. Officer active across 1 company, notably Reneo Pharmaceuticals, Inc.. Cumulatively, 2 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €54k. Activity tracked since 25 August 2021. The latest transaction was filed on 10 December 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Flesher Gregory J. is the President and CEO of Reneo Pharmaceuticals, Inc. He leads the company with a focus on developing innovative treatments for metabolic diseases. His leadership and strategic vision are essential in guiding Reneo's research and development efforts aimed at improving patients' quality of life.